{"schema_version":"secwatch.filing_event.v1","accession":"0001801170-26-000196","form_type":"8-K","ticker":"CLOV","cik":"0001801170","company_name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","filed_at":"2026-08-05T20:07:40+00:00","discovered_at":"2026-08-05T20:09:00.248288+00:00","generated_at":"2026-08-05T20:10:22.322917+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Clover Health Q2 2026 GAAP net income $28M, revenue up 56% YoY, raises full-year guidance","bullets":["Q2 GAAP net income $28M vs loss $10.6M YoY; revenue $743M (+56%).","Medicare Advantage membership 157,309 (+48% YoY); Insurance BER 87.6% (improved 80 bps).","Adjusted EBITDA $40.9M (+139% YoY); Adjusted net income $40.4M.","Raised FY 2026 guidance: revenue $2.92B-$3.00B, GAAP net income $20M-$35M, Adjusted EBITDA $70M-$85M.","CEO cites AI-powered Clover Assistant platform driving growth and profitability."],"urls":{"canonical":"https://secwatch.observer/filing/0001801170-26-000196","json":"https://secwatch.observer/filing/0001801170-26-000196.json","markdown":"https://secwatch.observer/filing/0001801170-26-000196.md","text":"https://secwatch.observer/filing/0001801170-26-000196.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1801170/000180117026000196/0001801170-26-000196-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1801170/000180117026000196/clov-20260805.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-05T20:10:22.322917+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}